trending Market Intelligence /marketintelligence/en/news-insights/trending/husm3qsb_-a_fffvgomqjq2 content esgSubNav
In This List

ImmunoGen board member to step down

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


ImmunoGen board member to step down

ImmunoGen Inc. said its board member Daniel Junius will not stand for re-election at the upcoming annual meeting of the company.

Junius is the former president and CEO of the Waltham, Mass.-based company that develops therapies for cancer.